Eversept Partners as of June 30, 2018
Portfolio Holdings for Eversept Partners
Eversept Partners holds 68 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Quality Care Properties | 10.8 | $24M | 1.1M | 21.51 | |
| R1 Rcm | 7.2 | $16M | 1.8M | 8.68 | |
| Aerie Pharmaceuticals | 7.0 | $15M | 227k | 67.55 | |
| Radius Health Com New | 6.3 | $14M | 469k | 29.47 | |
| Zogenix Com New | 5.7 | $13M | 284k | 44.20 | |
| Glaxosmithkline Sponsored Adr | 4.7 | $10M | 253k | 40.84 | |
| Sanofi Sponsored Adr (SNY) | 3.9 | $8.5M | 213k | 40.01 | |
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 3.7 | $8.1M | 30k | 271.28 | |
| BioMarin Pharmaceutical (BMRN) | 3.6 | $7.9M | 84k | 94.20 | |
| Teligent | 3.3 | $7.3M | 2.1M | 3.46 | |
| Sage Therapeutics (SAGE) | 3.1 | $6.8M | 43k | 156.53 | |
| Alnylam Pharmaceuticals (ALNY) | 2.9 | $6.3M | 64k | 98.49 | |
| Ensign (ENSG) | 2.7 | $6.0M | 166k | 35.87 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.7 | $5.9M | 35k | 169.96 | |
| Arena Pharmaceuticals Com New | 2.7 | $5.8M | 134k | 43.60 | |
| Sarepta Therapeutics (SRPT) | 2.4 | $5.3M | 40k | 132.18 | |
| Nevro (NVRO) | 1.7 | $3.8M | 47k | 79.85 | |
| Abbott Laboratories (ABT) | 1.3 | $2.8M | 46k | 60.99 | |
| athenahealth | 1.2 | $2.5M | 16k | 159.14 | |
| Tesaro | 1.1 | $2.3M | 53k | 44.47 | |
| Anaptysbio Inc Common (ANAB) | 1.1 | $2.3M | 33k | 71.04 | |
| Abiomed | 1.0 | $2.3M | 5.6k | 409.05 | |
| Apellis Pharmaceuticals (APLS) | 1.0 | $2.2M | 98k | 22.00 | |
| ArQule | 0.9 | $2.1M | 374k | 5.53 | |
| Argenx Se Sponsored Adr (ARGX) | 0.9 | $2.0M | 24k | 82.86 | |
| Ascendis Pharma A S Sponsored Adr (ASND) | 0.9 | $2.0M | 30k | 66.52 | |
| Invacare Corporation | 0.8 | $1.9M | 100k | 18.60 | |
| Caretrust Reit (CTRE) | 0.8 | $1.7M | 101k | 16.89 | |
| Medicines Company | 0.7 | $1.4M | 39k | 36.70 | |
| Cymabay Therapeutics | 0.7 | $1.4M | 107k | 13.42 | |
| Amarin Corp Spons Adr New | 0.7 | $1.4M | 460k | 3.09 | |
| Puma Biotechnology (PBYI) | 0.6 | $1.4M | 24k | 59.15 | |
| Tandem Diabetes Care Com New (TNDM) | 0.6 | $1.3M | 61k | 22.02 | |
| Haemonetics Corporation (HAE) | 0.6 | $1.3M | 15k | 89.68 | |
| Immunomedics | 0.6 | $1.3M | 55k | 23.67 | |
| Myokardia | 0.6 | $1.3M | 26k | 49.65 | |
| Madrigal Pharmaceuticals (MDGL) | 0.6 | $1.3M | 4.5k | 279.69 | |
| eHealth (EHTH) | 0.6 | $1.2M | 57k | 22.10 | |
| Anthem (ELV) | 0.5 | $1.2M | 5.0k | 238.03 | |
| Akorn | 0.5 | $1.2M | 70k | 16.59 | |
| Tg Therapeutics (TGTX) | 0.5 | $1.1M | 80k | 13.15 | |
| Dicerna Pharmaceuticals | 0.5 | $1.0M | 85k | 12.25 | |
| Centene Corporation (CNC) | 0.5 | $986k | 8.0k | 123.21 | |
| BioCryst Pharmaceuticals (BCRX) | 0.4 | $854k | 149k | 5.73 | |
| Cellectis S A Sponsored Ads (CLLS) | 0.4 | $849k | 30k | 28.29 | |
| Array BioPharma | 0.4 | $812k | 48k | 16.78 | |
| Vericel (VCEL) | 0.3 | $726k | 75k | 9.70 | |
| Arbutus Biopharma (ABUS) | 0.3 | $712k | 98k | 7.30 | |
| Iovance Biotherapeutics (IOVA) | 0.3 | $704k | 55k | 12.80 | |
| Epizyme | 0.3 | $643k | 47k | 13.55 | |
| Albireo Pharma | 0.3 | $640k | 18k | 35.50 | |
| Affimed Therapeutics B V | 0.3 | $638k | 387k | 1.65 | |
| Global Blood Therapeutics In | 0.3 | $624k | 14k | 45.20 | |
| Foamix Pharmaceuticals SHS | 0.2 | $539k | 108k | 5.01 | |
| Melinta Therapeutics | 0.2 | $488k | 77k | 6.35 | |
| IntriCon Corporation | 0.2 | $484k | 12k | 40.30 | |
| Model N (MODN) | 0.2 | $418k | 23k | 18.60 | |
| Dynavax Technologies Corp Com New (DVAX) | 0.2 | $412k | 27k | 15.25 | |
| Ophthotech | 0.2 | $407k | 149k | 2.73 | |
| Peregrine Pharmaceuticals (CDMO) | 0.2 | $394k | 100k | 3.92 | |
| Seaspine Holdings | 0.2 | $390k | 31k | 12.62 | |
| Celyad Sa Adr | 0.2 | $382k | 13k | 29.72 | |
| Deciphera Pharmaceuticals | 0.2 | $375k | 9.5k | 39.35 | |
| Iradimed (IRMD) | 0.2 | $365k | 18k | 20.75 | |
| Magellan Health Com New | 0.1 | $288k | 3.0k | 95.95 | |
| Dermira | 0.1 | $184k | 20k | 9.20 | |
| Conformis | 0.1 | $159k | 127k | 1.25 | |
| Galmed Pharmaceuticals SHS | 0.1 | $119k | 10k | 11.90 |